Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Metronomic capecitabine as an immune modulator in gliobla... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
0
Authors
David Peereboom
15 more
David Peereboom
•
Defne Bayık
13 more
•
Justin Lathia
Published
June 2, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Medicine
Cancer Oncology
Clinical Trials
Immunology
Internal Medicine
Show all topics
DOI
10.1101/655688
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Medicine
Cancer Oncology
Clinical Trials
Immunology
Internal Medicine
Show all topics
DOI
10.1101/655688
License
cc-no
